Clinical Advisor Day Rate UK: What to Charge in 2026

What a clinical advisor day rate actually looks like in the UK

If a healthtech founder just asked what your day rate is and you froze, you are not alone. Most healthcare experts we speak to at Orbion Connect have never been asked to price their own time outside NHS payscales, and they either lowball themselves by 60% or quote a number that ends the conversation. The clinical advisor day rate UK healthtech companies actually pay in 2026 sits, for the most part, between £750 and £2,500, with hourly work billed at £150 to £400 depending on your specialism, seniority and how commercial the request is.

Those are not made-up numbers. UK consulting rate benchmarks published for healthtech advisory work in 2026 land in exactly that band, with specialist rates pushing to £2,500 per day and standard clinical input closer to the £750 to £1,500 range (Medical Consulting Group pricing guide, Kolabtree consultant rates). The band is wide because clinical advisor is not one job. It covers a consultant radiologist reviewing an AI triage model, a senior stroke nurse designing a patient pathway, a clinical scientist calibrating an assay, a pharmacist checking a decision-support tool, and a physiotherapist validating a rehab app. Each has different market rates. So do not read one Reddit thread and assume the number applies to you.

The strong opinion: charge by outcome, not by hour, unless you are new

Here is the view that most rate guides miss. If you are more than three years into paid healthtech work, hourly billing is quietly costing you money. The advisor who moves off hours and onto a monthly retainer, a fixed project fee, or an outcome-linked structure ends up with a higher effective rate every single time, because founders stop rationing your time and start looping you in early.

Hourly billing punishes you twice. First, you cannot bill for the thinking you do in the shower before a meeting, which is where the actual advice comes from. Second, hourly meters make founders defensive about pinging you for the ten-minute question that would have saved them two months. You want to be the person they call at 9pm on a Tuesday. You cannot be that person on a stopwatch.

The rule of thumb we use with Orbion Connect experts: hourly for pilots (three or four sessions, both sides testing the fit), then move to monthly retainer at £2,000 to £5,000 once the relationship is real. Ranges of £2,000 to £5,000 per month are consistent with UK healthtech consulting benchmarks for 2026 (Medical Consulting Group). Project rates should be quoted as a fixed number with a clear deliverable, priced against the day rate you would have charged times a 1.3 to 1.5 risk multiplier.

What each expert type should actually charge

Broad ranges hide the reality. Here is how the day rate splits by discipline in the UK healthtech market as of mid 2026, based on live engagements we see through Orbion Connect and public benchmarks.

Consultant doctors (any specialty), post-CCT with 5+ years experience. £1,200 to £2,500 per day. Regulatory-facing work (MHRA submissions, clinical evaluation reports under MDR) tops the range. Marketing input and light advisory work sits at the lower end. A cardiologist reviewing an ECG algorithm should not be quoting the same rate as a GP writing blog posts.

Clinical scientists, biomedical scientists, pathologists. £900 to £1,800 per day. Higher when the work touches assay design, IVDR validation, or laboratory workflow integration. This group consistently undercharges. Your training is longer than most consultants and your work is directly load-bearing for regulatory submissions.

Senior nurses, midwives, advanced practitioners. £700 to £1,500 per day. Higher for clinical safety officer work, patient safety incident review, or CQC-facing product design. The market has quietly reset upward in the past 18 months as nurse-led services become the dominant NHS delivery model and healthtech companies wake up to that.

Allied health professionals (physiotherapists, OTs, dietitians, SLTs, radiographers). £600 to £1,400 per day. Higher for radiographers on imaging AI, dietitians on nutrition apps with medical claims, and OTs on assistive tech. HCPC-registered clinicians should be charging at parity with equivalent-seniority nurses. Many are not.

Pharmacists (community and hospital). £700 to £1,600 per day. Higher for anything involving prescribing tools, medicines optimisation, or clinical decision support. The RPS is one of the more sensible regulators here, but you still need to think about the conflicts you are declaring.

Health economists, HTA specialists, NICE pathway experts. £1,000 to £2,500 per day. This is the highest-margin corner of the market right now because payer evidence has become a life-or-death topic for scaling healthtech companies. If you have ever built a NICE submission, you are underpriced at anything below £1,500.

These are day rates for confident, delivering work. If you are new to healthtech advisory work, take 20% off and use it as a runway to build case studies. Do not stay there.

Three examples that make the ranges real

The startup example: a senior stroke nurse and a remote monitoring company. A band 8a stroke specialist nurse we work with started at £150 per hour with a Series A remote monitoring startup, thinking she was being ambitious. Within four months she had rewritten their entire post-discharge pathway, sat in three payer meetings, and become the reason their NHS pilot converted. She moved to a £3,500 per month retainer plus 0.4% equity, which on a £22m post-money valuation is worth £88,000 on paper. The lesson is that founders pay for indispensable, not for hours. Get indispensable, then reprice.

The NHS example: a consultant clinical scientist and a diagnostics company. A clinical scientist in a large NHS pathology network was approached by an IVD company preparing for IVDR resubmission. They offered £800 per day. She counter-offered £1,500 per day framed as a project rate for the CER (clinical evaluation report) input, plus £2,500 per month retainer for ongoing advisory. They took the £1,500 without a blink and pushed back on the retainer. She held. Six months later she is on a £4,000 per month retainer because they realised the audit-readiness she gives them is worth more than the day rate on the CER.

The failure example: a physiotherapist and a rehab app. A well-known clinical physiotherapist agreed to advise a rehab app for £500 per day, capped at four days per month, no retainer, no equity, no defined scope. Within six weeks she was on WhatsApp daily, reviewing patient scripts unpaid, and getting tagged in every marketing email as "our clinical lead." She had to walk away when the CEO started implying she was liable for clinical safety without giving her sign-off authority. The failure was not the £500 day rate. It was accepting an open-ended relationship without defined scope, without indemnity in writing, and without any retainer to make the founder feel the cost of her time. This is the single most common failure mode we see. Fix the scope before you argue about the rate.

The equity question you need a clear rule on

Equity for advisors in UK healthtech generally lands between 0.1% and 1%, vesting over two years, with a one-year cliff (Promise Legal advisory board equity guide). Anything above 1% for a non-founding advisor is unusual and should make you look hard at what the founder is actually asking for.

Our rule for experts on Orbion Connect: never take equity in place of cash if you cannot afford to work for free. Take equity on top of a defensible cash floor. If a founder cannot afford your day rate, that is fine, but the equity has to reflect that you are subsidising the round, not just topping up your day rate. That usually means north of 0.5% for a genuinely load-bearing clinical advisor pre-Series A, on a two-year vest with a three-month cliff and single-trigger acceleration on change of control. Anything less generous than that and you are effectively lending the company your credibility at 0% interest. See the range and structure play out in real Orbion engagements on our case studies page.

Two things to check before you send the invoice

Your regulator's rules on external work. If you are a doctor, the GMC expects you to declare and manage conflicts of interest under Good Medical Practice, and NHS trusts require job-plan approval for private and fee-paying work under the code of conduct on private practice (NHS Employers code of conduct). If you are an NMC, HCPC, GPhC or other regulated professional, the equivalent obligation exists. Get the paperwork done before the money hits your account, not after.

Your indemnity. NHS indemnity covers you for NHS work only. Healthtech advisory work is not covered. You need either the company's professional indemnity policy to explicitly name you, or your own MDU/MPS/RCN/CSP policy extended to cover commercial advisory work. Ask before you sign. If the founder does not know what you are talking about, that is a red flag about how they think about clinical risk, and you should adjust your rate upward accordingly.

Orbion Connect exists to make this market legible for both sides. Healthcare experts on our platform benchmark their rates against live engagements, and healthtech companies get to see what serious clinical input actually costs. If you want to see how we structure day rates, retainers and equity for the experts we work with, take a look at how we operate.

You are worth more than NHS payscales suggest. Charge accordingly, structure the work properly, and stop billing by the hour the moment you can.